Current management of lesions associated with an increased risk of breast cancer
M Morrow, SJ Schnitt, L Norton - Nature reviews Clinical oncology, 2015 - nature.com
High-risk breast lesions, which comprise benign lesions and in situ carcinomas (lobular
carcinoma in situ and ductal carcinoma in situ), are clinically, morphologically, and …
carcinoma in situ and ductal carcinoma in situ), are clinically, morphologically, and …
Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis
While ductal carcinoma in situ (DCIS) is seldom life threatening, the management of DCIS
remains a dilemma for patients and their physicians. Aggressive treatment reduces the risk …
remains a dilemma for patients and their physicians. Aggressive treatment reduces the risk …
Incidence of primary breast cancer in Iran: Ten-year national cancer registry data report
Breast cancer is the leading type of malignancy and the leading cause of cancer-related
deaths in women worldwide. The screening programs and advances in the treatment of …
deaths in women worldwide. The screening programs and advances in the treatment of …
Air pollution, clustering of particulate matter components, and breast cancer in the sister study: a US-wide cohort
Background: Particulate matter (PM) is a complex mixture. Geographic variations in PM may
explain the lack of consistent associations with breast cancer. Objective: We aimed to …
explain the lack of consistent associations with breast cancer. Objective: We aimed to …
Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early‐stage breast cancer
F Wang‐Johanning, M Li, FJ Esteva… - … journal of cancer, 2014 - Wiley Online Library
A simple and accurate test to detect early‐stage breast cancer has not been developed.
Previous studies indicate that the level of human endogenous retrovirus type K (group …
Previous studies indicate that the level of human endogenous retrovirus type K (group …
Cis-acting super-enhancer lncRNAs as biomarkers to early-stage breast cancer
AS Ropri, RS DeVaux, J Eng, SV Chittur… - Breast Cancer …, 2021 - Springer
Background Increased breast cancer screening over the past four decades has led to a
substantial rise in the diagnosis of ductal carcinoma in situ (DCIS). Although DCIS lesions …
substantial rise in the diagnosis of ductal carcinoma in situ (DCIS). Although DCIS lesions …
Predicting and overcoming chemotherapeutic resistance in breast cancer
KH Chun, JH Park, S Fan - Translational Research in Breast Cancer …, 2017 - Springer
Our understanding of breast cancer and its therapeutic approach has improved greatly due
to the advancement of molecular biology in recent years. Clinically, breast cancers are …
to the advancement of molecular biology in recent years. Clinically, breast cancers are …
Ductal carcinoma in situ: current concepts in biology, imaging, and treatment
M Shehata, L Grimm, N Ballantyne… - Journal of breast …, 2019 - academic.oup.com
Ductal carcinoma in situ (DCIS) of the breast is a group of heterogeneous epithelial
proliferations confined to the milk ducts that nearly always present in asymptomatic women …
proliferations confined to the milk ducts that nearly always present in asymptomatic women …
Screening mammography outcomes: risk of breast cancer and mortality by comorbidity score and age
Background Potential benefits of screening mammography among women ages 75 years
and older remain unclear. Methods We evaluated 10-year cumulative incidence of breast …
and older remain unclear. Methods We evaluated 10-year cumulative incidence of breast …
Ductal carcinoma in situ: the whole truth
U Parikh, CM Chhor… - American Journal of …, 2018 - Am Roentgen Ray Soc
OBJECTIVE. Ductal carcinoma in situ (DCIS) is a noninvasive malignant breast disease
traditionally described as a precursor lesion to invasive breast cancer. With screening …
traditionally described as a precursor lesion to invasive breast cancer. With screening …